drug discovery Archives - Page 2 of 7

Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration

Sophie Rose2021-01-18T09:56:07+00:00

Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration Ongoing collaboration extended for another 12 months and successfully progresses into late stage hit-to-lead optimisation phase Cambridge and London, UK, 18 January 2021: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent [...]

Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaborationSophie Rose2021-01-18T09:56:07+00:00

SARS-CoV-2 Drug Discovery: Targeting Viral Ion Channels
Gallery

SARS-CoV-2 Drug Discovery: Targeting Viral Ion Channels

Sophie Rose2021-01-07T16:10:40+00:00

Image above: As well as the spike (S) protein which binds to human cells, there are other transmembrane proteins including the M class and the viroporin envelope protein (E) ion channel. Ion channels are well validated drug discovery targets based on their widespread distribution in the human body and involvement in many critical [...]

SARS-CoV-2 Drug Discovery: Targeting Viral Ion ChannelsSophie Rose2021-01-07T16:10:40+00:00

Metrion and Grünenthal extend Ion Channel Research Agreement
Gallery

Metrion and Grünenthal extend Ion Channel Research Agreement

Sophie Rose2020-11-06T10:11:31+00:00

Introduction Metrion Biosciences have had a longstanding relationship providing drug discovery research services to Grünenthal GmbH, a privately owned pharmaceutical company and global leader in pain management and related diseases. Grünenthal develop medication for patients with severe and debilitating diseases and high unmet medical needs and have a long track record of bringing innovative [...]

Metrion and Grünenthal extend Ion Channel Research AgreementSophie Rose2020-11-06T10:11:31+00:00

ELRIG Drug Discovery Digital 2020

Sophie Rose2020-08-20T14:59:53+00:00

Metrion Biosciences will be attending the virtual ELRIG Drug Discovery 2020 meeting taking place between 6th and 16th October 2020. Please email info@metrionbiosciences.com if you wish to arrange a meeting with one of our attendees. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest bioscience [...]

ELRIG Drug Discovery Digital 2020Sophie Rose2020-08-20T14:59:53+00:00

Safety Pharmacology Society Annual Meeting (2020)

Sophie Rose2020-08-20T14:06:05+00:00

Metrion Biosciences look forward to attending, presenting posters and exhibiting at the Virtual Safety Pharmacology Society (SPS) Annual Meeting to be held from 14th to 17th September 2020. Metrion will be located at Booth # 400 in the exhibits hall for the duration of the virtual event. Our collaborative poster with Nanion Technologies will be [...]

Safety Pharmacology Society Annual Meeting (2020)Sophie Rose2020-08-20T14:06:05+00:00

An Interview with Damian Bell by Artem Kondratskyi
Gallery

An Interview with Damian Bell by Artem Kondratskyi

Sophie Rose2020-07-19T18:36:26+00:00

Introducing Damian Bell: as a new member of the team at Metrion we are using an abridged version of an interview by Artem Kondratskyi for ionchannellibrary.com. A big thank you to Artem for sharing this interview and a quick plug for his website – we highly recommend it as an excellent resource for anyone [...]

An Interview with Damian Bell by Artem KondratskyiSophie Rose2020-07-19T18:36:26+00:00

Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines

Sophie Rose2020-05-11T12:31:08+00:00

Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines Part of the US FDA’s Comprehensive in vitro Proarrythmia Assay (CiPA) Initiative Cambridge, UK, 07 April 2020: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today [...]

Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicinesSophie Rose2020-05-11T12:31:08+00:00

Metrion-Nanion Collaborative Webinar: Validation and optimisation of automated patch clamp voltage-gated Ca2+ channel assays

Sophie Rose2020-04-10T19:04:07+00:00

Metrion Biosciences and Nanion Technologies look forward to hosting their first collaborative webinar on Tuesday 28th April entitled: Validation and optimization of automated patch clamp voltage-gated Ca2+ channel assays. The webinar will feature Metrion's CSO Dr. Marc Rogers. Marc will outline the development, optimisation and validation of a range of voltage-gated Ca2+ channel assays on [...]

Metrion-Nanion Collaborative Webinar: Validation and optimisation of automated patch clamp voltage-gated Ca2+ channel assaysSophie Rose2020-04-10T19:04:07+00:00

RSC Ion Channel Symposium

Sophie Rose2019-07-29T15:39:14+00:00

Metrion Biosciences are sponsoring and exhibiting (booth number to be added at a later date) at the RSC Ion Channel Symposium taking place from Monday 24th- Tuesday 25th February 2020 at the Wellcome Trust Genome Campus Conference Centre, Hinxton, Cambridge. Metrion will also be presenting a poster (title to be added at a later date). [...]

RSC Ion Channel SymposiumSophie Rose2019-07-29T15:39:14+00:00

64th Annual Meeting of the Biophysical Society

Sophie Rose2020-01-27T17:12:30+00:00

Metrion Biosciences will be attending and exhibiting at the 64th Annual Meeting of the Biophysical Society to be held at the San Diego Convention Centre in San Diego, California from 15th - 19th February 2020. Metrion will be exhibiting at booth number 214 in the Exhibits Hall for the duration of the meeting and will [...]

64th Annual Meeting of the Biophysical SocietySophie Rose2020-01-27T17:12:30+00:00